Expand IMRX Menu
IMRX MENU

IMRX Latest Press Releases

-- August 26, 2026 --

Immuneering Comments on Today's FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients Globe Newswire 5:16 PM

-- August 5, 2026 --

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 7:30 AM

-- July 21, 2026 --

Publication in Cancer Research Details Atebimetinib's Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition Globe Newswire 4:05 PM

-- July 17, 2026 --

Immuneering Corporation Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- July 6, 2026 --

Kalaris Appoints Laurie Keating to Board of Directors Globe Newswire 4:05 PM

-- June 15, 2026 --

Immuneering Appoints Andrew Gengos as Chief Financial Officer Globe Newswire 7:30 AM

-- June 11, 2026 --

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Globe Newswire 7:30 AM

-- June 1, 2026 --

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO Globe Newswire 7:30 AM

-- May 21, 2026 --

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy Globe Newswire 5:00 PM

-- May 15, 2026 --

Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 7:35 AM

-- April 21, 2026 --

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting Globe Newswire 4:05 PM

-- April 20, 2026 --

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond Globe Newswire 9:00 AM

-- April 6, 2026 --

Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes